Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL

IDH1 and IDH2 mutations (IDH1/2Mut) are recognized as recurrent genetic alterations in acute myeloid leukemia (AML) and associated with both clinical impact and therapeutic opportunity due to the recent developme...

Source: Journal of Hematology and Oncology - May 3, 2021 Category: Hematology Authors: Mathieu Simonin, Aline Schmidt, Christophe Bontoux, Marie- Émilie Dourthe, Etienne Lengliné, Guillaume P. Andrieu, Ludovic Lhermitte, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Françoise Huguet, Isabelle Arnoux, Stéphane Ducassou, Elizabeth Tags: Rapid communication Source Type: research